CO [China Cord Blood] SC 13D/A: (Original Filing)

[CHINA CORD BLOOD CORPORATION CONVERSION NOTICE Note Company Shares Reference is made to the Senior Convertible Note (the “ Date of Conversion: April 6, 2017 Aggregate Principal amount to be converted: USD65,000,000 Please confirm the following information: Conversion Price: USD2.838 Number of Shares]

By | 2017-04-06T14:29:55+00:00 April 6th, 2017|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] SC 13D/A: CHINA CORD BLOOD CORPORATION CONVERSION NOTICE Note Company

[CHINA CORD BLOOD CORPORATION CONVERSION NOTICE Note Company Shares Reference is made to the Senior Convertible Note (the “ Date of Conversion: April 6, 2017 Aggregate Principal amount to be converted: USD65,000,000 Please confirm the following information: Conversion Price: USD2.838 Number of Shares]

By | 2017-04-06T14:30:24+00:00 April 6th, 2017|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] SC 13G/A: (Original Filing)

[SCHEDULE 13G/A Amendment No. 12 China Cord Blood Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 698659109 (CUSIP Number) March 30, 2017 (Date of Event Which Requires Filing of this Statement) ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) *The ]

By | 2017-04-01T03:13:31+00:00 March 31st, 2017|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] SC 13G/A: SCHEDULE 13G/A Amendment No. 12 China Cord Blood

[SCHEDULE 13G/A Amendment No. 12 China Cord Blood Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 698659109 (CUSIP Number) March 30, 2017 (Date of Event Which Requires Filing of this Statement) ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) *The ]

By | 2017-04-01T03:13:50+00:00 March 31st, 2017|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: China Cord Blood Corporation Reports Financial Results for

[China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2017 3Q17 Added 19,712 New Subscribers 3Q17 Revenue Up 18.6% YOY to RMB200.9 Million ($28.9 Million) 3Q17 Operating Income Reached RMB101.7 Million ($14.6 Million) Conference Call to be Held ]

By | 2017-02-25T03:22:12+00:00 February 24th, 2017|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: (Original Filing)

[China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2017 3Q17 Added 19,712 New Subscribers 3Q17 Revenue Up 18.6% YOY to RMB200.9 Million ($28.9 Million) 3Q17 Operating Income Reached RMB101.7 Million ($14.6 Million) Conference Call to be Held ]

By | 2017-02-25T03:21:48+00:00 February 24th, 2017|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] SC 13G/A: (Original Filing)

[SCHEDULE 13G/A Amendment No. 11 China Cord Blood Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 698659109 (CUSIP Number) December 31, 2016 (Date of Event Which Requires Filing of this Statement) ☐ Rule13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) * C]

By | 2017-02-14T03:27:45+00:00 February 13th, 2017|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] SC 13G/A: SCHEDULE 13G/A Amendment No. 11 China Cord Blood

[SCHEDULE 13G/A Amendment No. 11 China Cord Blood Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 698659109 (CUSIP Number) December 31, 2016 (Date of Event Which Requires Filing of this Statement) ☐ Rule13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) * C]

By | 2017-02-14T03:28:07+00:00 February 13th, 2017|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: (Original Filing)

[China Cord Blood Corporation Receives Notice of Entry Into Conditional Sale Agreement HONG KONG, China, January 4 , 2017 - China Cord Blood Corporation In connection with the Share Purchase Agreement, other pending share sale arrangements entered into by Golden Meditech and Nanjing Xinjiekou Departm]

By | 2017-01-07T18:17:09+00:00 January 4th, 2017|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: China Cord Blood Corporation Receives Notice of Entry

[China Cord Blood Corporation Receives Notice of Entry Into Conditional Sale Agreement HONG KONG, China, January 4 , 2017 - China Cord Blood Corporation In connection with the Share Purchase Agreement, other pending share sale arrangements entered into by Golden Meditech and Nanjing Xinjiekou Departm]

By | 2017-01-07T18:17:18+00:00 January 4th, 2017|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar